Biologics and other targeted therapies are creating opportunities for … [Read More...]
White Papers
The Evolving Role of Thermoforming Suppliers in Medical Packaging Design
Today’s medical device OEMs need thermoforming partners to take on expanded … [Read More...]
Sponsored Content
Silicone Materials for Long-term Medical Implants: Innovate for the Future
By Feifei Lin, Ph.D., Business Development Manager, Healthcare, Elkem Silicones USA Corp. With the growth of the aging population, the number of age-related diseases has increased. Every year … [Read More...]
How K2M Tackled UDI and What Comes Next with help from Reed Tech
Mark Zellers, Quality Assurance Specialist at K2M, is responsible for ensuring his company’s data is accurate and kept up-to-date with all sorts of outside stakeholders. One of his colleagues handles … [Read More...]
Efficiency, Transparency and Standardization: The Roadmap for Improved Data Collection in Medical Device Clinical Trials
Implementing a unified data platform for medical device trials can yield significant improvements in efficiency, transparency, and standardization, providing resource- and budget-strapped trial teams … [Read More...]
Mergers & Acquisitions.
Stryker extends deadline on $1.4B K2M buy as shareholders sue
Stryker (NYSE:SYK) yesterday filed to extend the anti-trust deadline on its $1.4 billion acquisition of K2M (NSDQ:KTWO) to give the U.S. Federal Trade Commission more time to examine the deal, as shareholders filed suit to block the merger, K2M said today. The new FTC filing pushes the anti-monopoly waiting period out to Nov. 16, the Leesburg, Va.-based spinal […]
Getinge’s Atrium Medical deals biosurg biz to SeCQure Surgical parent
Getinge (PINK:GETI B) subsidiary Atrium Medical said today that it agreed to deal its biosurgery business to the parent company of SeCQure Surgical for an undisclosed amount. Göteborg, Sweden-based Getinge acquired the biosurgery unit, which makes soft tissue reinforcement devices, in the $680 million deal for Atrium back in 2011. Today Getinge said it agreed to sell the business, which […]
Fresenius plunges on missed prelims, guidance cut
Fresenius (NYSE:FMS) shares closed down some $17% yesterday after it cut its outlook for the rest of the year on lower-than-expected third-quarter results. The German dialysis giant released preliminary figures for the three months ended Sept. 30, saying it expects to report profits of €285 million on sales of €4.06 billion. Analysts were looking for sales of €4.12 billion. […]
Boston Scientific closes $600m Augmenix buyout
Boston Scientific (NYSE:BSX) said yesterday that it closed the $600 million acquisition of Augmenix and its SpaceOar device. The deal for Bedford, Mass.-based Augmenix, announced in September, called for $500 million in up-front cash and another $100 million pegged to sales-based milestones. “This close marks the third completed acquisition in 2018 for the company’s urology & […]
Varian acquires cloud-based oncology software dev Noona Healthcare
Varian Medical (NYSE:VAR) said today it acquired cloud-based, oncology-focused software developer Noona Healthcare for an undisclosed amount. Palo Alto, Calif.-based Varian said that Noona developed a cloud-based mobile service intended to capture cancer patient-reported outcomes. The system allows clinics to capture PROs and communicate with patients, the company added. “PROs represent a growing and significant metric […]
Wright Medical closes $435m Cartiva buy
Wright Medical (NSDQ:WMGI) said today that it closed its $435 million buyout of Cartiva and its synthetic cartilage implant for treating arthritis in the big toe. Alpharetta, Ga.-based Cartiva won pre-market approval from the FDA for the SCI implant in July 2016 (the device won CE Mark approval in the European Union back in 2002 and is also on the market in […]
Delaware court fast-tracks Channel Medsystems suit against Boston Scientific
A Delaware state court yesterday expedited a lawsuit brought by Channel Medsystems against Boston Scientific (NYSE:BSX) over a failed $275 million buyout. The lawsuit alleges that Boston Scientific spiked the deal over a former Channel employee’s alleged scheme to embezzle nearly $3 million from the women’s health company. Emeryville, Calif.-based Channel Medsystems developed Cerene, a cryogen-based endometrial ablation system […]
MassDevice Network
@MassDevice
LinkedIn